490 related articles for article (PubMed ID: 31228643)
1. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
[TBL] [Abstract][Full Text] [Related]
2. Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
Commandeur S; Lin MY; van Meijgaarden KE; Friggen AH; Franken KL; Drijfhout JW; Korsvold GE; Oftung F; Geluk A; Ottenhoff TH
Eur J Immunol; 2011 Oct; 41(10):2925-36. PubMed ID: 21728172
[TBL] [Abstract][Full Text] [Related]
3. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
4. DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts.
Pandey K; Singh S; Bhatt P; Medha ; Sharma M; Chaudhry A; Sharma S
Microb Pathog; 2019 Jan; 126():399-406. PubMed ID: 30476579
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Singh S; Saraav I; Sharma S
Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
[TBL] [Abstract][Full Text] [Related]
6. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.
Pandey K; Sharma M; Saarav I; Singh S; Dutta P; Bhardwaj A; Sharma S
Int J Mycobacteriol; 2016 Mar; 5(1):34-43. PubMed ID: 26927988
[TBL] [Abstract][Full Text] [Related]
8. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
Pathakumari B; Devasundaram S; Maddineni P; Raja A
Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
[TBL] [Abstract][Full Text] [Related]
9. Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.
Liu SD; Su J; Zhang SM; Dong HP; Wang H; Luo W; Wen Q; He JC; Yang XF; Ma L
J Cell Mol Med; 2016 Sep; 20(9):1718-28. PubMed ID: 27072810
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic potential of MPT63-derived HLA-A*0201-restricted CD8+ T-cell epitopes for active pulmonary tuberculosis.
Duan Z; Li D; Jia Q; Xu J; Chen X; Xu Z; Liu H; Chen B; Wen J
Microbiol Immunol; 2015 Dec; 59(12):705-15. PubMed ID: 26577013
[TBL] [Abstract][Full Text] [Related]
11. The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.
Commandeur S; van den Eeden SJ; Dijkman K; Clark SO; van Meijgaarden KE; Wilson L; Franken KL; Williams A; Christensen D; Ottenhoff TH; Geluk A
Vaccine; 2014 Jun; 32(29):3580-8. PubMed ID: 24837764
[TBL] [Abstract][Full Text] [Related]
12. A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis.
Rai PK; Chodisetti SB; Maurya SK; Nadeem S; Zeng W; Janmeja AK; Jackson DC; Agrewala JN
J Transl Med; 2018 Oct; 16(1):279. PubMed ID: 30305097
[TBL] [Abstract][Full Text] [Related]
13. Specific immune responses induced by multi-epitope DNA derived from Mycobacterium tuberculosis DosR antigens.
Moradi J; Izad M; Tabrizi M; Mosavari N; Esmaeili B; Feizabadi MM
Acta Microbiol Immunol Hung; 2018 Jun; 65(2):193-209. PubMed ID: 29552899
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia.
Arroyo L; Rojas M; Franken KL; Ottenhoff TH; Barrera LF
Clin Vaccine Immunol; 2016 Oct; 23(10):813-824. PubMed ID: 27489136
[TBL] [Abstract][Full Text] [Related]
15. T cell recall response of two hypothetical proteins (Rv2251 and Rv2721c) from Mycobacterium tuberculosis in healthy household contacts of TB - Possible subunit vaccine candidates.
Santhi D; Raja A
J Infect; 2016 Nov; 73(5):455-467. PubMed ID: 27404979
[TBL] [Abstract][Full Text] [Related]
16. T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia.
Riaño F; Arroyo L; París S; Rojas M; Friggen AH; van Meijgaarden KE; Franken KL; Ottenhoff TH; García LF; Barrera LF
Tuberculosis (Edinb); 2012 Mar; 92(2):148-59. PubMed ID: 22226907
[TBL] [Abstract][Full Text] [Related]
17. Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccination.
Coppola M; Ottenhoff TH
Semin Immunol; 2018 Oct; 39():88-101. PubMed ID: 30327124
[TBL] [Abstract][Full Text] [Related]
18. A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge.
Gao H; Yue Y; Hu L; Xu W; Xiong S
Vaccine; 2009 Aug; 27(39):5313-9. PubMed ID: 19615961
[TBL] [Abstract][Full Text] [Related]
19. An unbiased peptide-wide discovery approach to select Mycobacterium tuberculosis antigens that target CD8+ T cell response during infection.
Cayabyab MJ; Qin L; Kashino SS; Izzo A; Campos-Neto A
Vaccine; 2013 Oct; 31(42):4834-40. PubMed ID: 23933335
[TBL] [Abstract][Full Text] [Related]
20. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
Wang F; Mao L; Hou H; Wu S; Huang M; Yin B; Huang J; Zhu Q; Pan Y; Sun Z
Int Immunopharmacol; 2016 Mar; 32():39-45. PubMed ID: 26796515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
